Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

Radiation Treatment and Survival of Maxillary Sinus Carcinoma

상악동암의 방사선치료와 생존율

  • Oh W.Y. (Department of Radiation Oncology, Yonsei University, College of Medicine, Yonsei Cancer Center) ;
  • Kim G.E. (Department of Radiation Oncology, Yonsei University, College of Medicine, Yonsei Cancer Center) ;
  • Suh C.O. (Department of Radiation Oncology, Yonsei University, College of Medicine, Yonsei Cancer Center) ;
  • Loh J.K. (Department of Radiation Oncology, Yonsei University, College of Medicine, Yonsei Cancer Center) ;
  • Hong W.P. (Department of ENT, College of Medicine, Yonsei University) ;
  • Kim K.M. (Department of ENT, College of Medicine, Yonsei University) ;
  • Lee W.S. (Department of ENT, College of Medicine, Yonsei University)
  • 오원용 (연세대학교 치료방사선과 연세암센타) ;
  • 김귀언 (연세대학교 치료방사선과 연세암센타) ;
  • 서창옥 (연세대학교 치료방사선과 연세암센타) ;
  • 노준규 (연세대학교 치료방사선과 연세암센타) ;
  • 홍원표 (연세대학교 의과대학 이비인후과학교실) ;
  • 김광문 (연세대학교 의과대학 이비인후과학교실) ;
  • 이원상 (연세대학교 의과대학 이비인후과학교실)
  • Published : 1987.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Irradiated 88 patients of Maxillary Sinus Carcinoma at Yonsei Cancer Center for 10years between 1971 and 1980 were retrospectively analysed. The majority of patients had very advanced disease(87.5% of $T_3\;and\;T_4$) and 17% of cervical lymph node involvement. 80.6% of all patients were epidermoid type. In 44 cases(50%), irradiation alone was performed. 28 cases(32%) of postoperative radiation after incomplete surgery and the remaining 16 cases(18%) of postoperative radiation after radical surgery were done. The majority of patients except 6 cases had irradiation a dose between 60Gy and 80Gy in 30-40 fractions over 6-8 weeks. The actuarial overall 3 and 5 year survival rate were 362% and 26%, respectively. The actuarial 5 year survival rate for 44 cases of radiation alone group was 14.1%, The actuarial 5 year survival rate for 28 cases of incomplete surgery and postoperative radiation group and 16 cases of radical surgery and postoperative radiation group were 312% and 67.4% respectively. In the actuarial 5 year survival rate according to the stage, stage II, III and IV were 79.5%, 20.9% and 0%. In recent, for the improvement of survival rate of advanced Maxillary Sinus Carcinoma at Yonsei Cancer Center, combined multidisplinary or trimodal treatment modality have been applied and in near time the more excellent results expect to be analyse.

Keywords